This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beekwilder, J.
Right arrow Articles by Bovy, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beekwilder, J.
Right arrow Articles by Bovy, A.
Agricola
Right arrow Articles by Beekwilder, J.
Right arrow Articles by Bovy, A.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, August 2006, p. 5670-5672, Vol. 72, No. 8
0099-2240/06/$08.00+0     doi:10.1128/AEM.00609-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

SHORT REPORT

Production of Resveratrol in Recombinant Microorganisms

Jules Beekwilder,* Rianne Wolswinkel, Harry Jonker, Robert Hall, C. H. Ric de Vos, and Arnaud Bovy

Plant Research International, P.O. Box 16, 6700 AA Wageningen, The Netherlands

Received 15 March 2006/ Accepted 16 June 2006


arrow
ABSTRACT
 
Resveratrol production in Saccharomyces cerevisiae was compared to that in Escherichia coli. In both systems, 4-coumarate:coenzyme A ligase from tobacco and stilbene synthase from grapes were expressed. When p-coumaric acid was used as the precursor, resveratrol accumulations in the culture medium were observed to be comparable in E. coli (16 mg/liter) and yeast (6 mg/liter).


arrow
INTRODUCTION
 
Resveratrol (3,5,4'-transhydroxystilbene) is one of the most widely studied representatives of the plant-produced polyphenols. It is well-known for its presence in red wine. As a component of grape skin (up to 0.1%), it is extracted, together with the colored anthocyanins, into red wine during fermentation. The health effect of red wine is believed to result from its high concentration of polyphenols, including resveratrol. A number of studies (recently reviewed in reference 8) have described the multiple beneficial effects of this molecule in humans, including anticarcinogenic effects and effects on low-density lipoproteins. Therefore, we set out to produce it in microbial systems, as an alternative to extraction from plant or chemical synthesis.

In plants, resveratrol is produced as a branch from the phenylpropanoid pathway (9). It is derived from p-coumaric acid, which is an intermediate in lignin production. By the action of 4-coumarate:coenzyme A (CoA) ligase (4CL) (EC 6.2.1.12), it is converted into coumaroyl-CoA. Coumaroyl-CoA and three units of malonyl-CoA are condensed into resveratrol by the action of stilbene synthase (STS) (EC 2.3.1.95) (Fig. 1).


Figure 1
View larger version (13K):
[in this window]
[in a new window]
  		FIG. 1. Biosynthetic pathway of resveratrol. The biosynthesis of resveratrol starts by the coupling of p-coumaric acid to CoA by the 4CL enzyme. Subsequently, coumaroyl-CoA is converted into resveratrol by sequential addition of three malonyl-CoA units with the release of carbon dioxide.

The 4CL2 gene (GenBank accession no. U50846) (5) was amplified from cDNA obtained from a young wounded leaf from Nicotiana tabacum cv. Samsun by use of oligonucleotides 5'-TATACCATGGAGAAAGATACAAAACAGG and 5'-GCGGCCGCTTAATTTGGAAGCCCAGCAG. The amplified fragment was cloned into vector pACYC-DUET1 (Novagen) by use of restriction enzymes NcoI and NotI. The STS gene from Vitis vinifera was amplified from plasmid HEAP25 (7) by use of oligonucleotides 5'-ATATAGATCTGGCTTCAGTCGAGGAAATTAGAAAC and 5'-ATATACTCGAGCTTAATTTGTAACCATAGGAATGC. The amplified fragment was introduced into pACYC-DUET1-4CL by use of BglII and XhoI restriction enzymes. The resulting plasmid, pAC-4CL-STS, was transferred to Escherichia coli BL21. A flask culture of this strain was grown in 2x YT medium (10 g/liter yeast extract, 16 g/liter tryptone, 5 g/liter NaCl) at 28°C and 250 rpm in 100 ml, supplemented with 5 mM p-coumaric acid (Sigma) and 0.1 mM IPTG (isopropyl-ß-D-thiogalactopyranoside). After 24 h of growth, the culture was extracted with ethyl acetate, and high-pressure liquid chromatography (HPLC) analysis of the extract showed the accumulation of a compound with a {lambda}max of 305 nm and elution at 28.9 min in the culture medium (Fig. 2). Both absorption spectrum and retention time of this compound corresponded to those of a standard of resveratrol (Sigma). Further identification using mass spectrometry revealed that this compound had an m/z value of 227.07 [M-H]–, thus confirming the identity of the product as resveratrol (Fig. 2). The formation of resveratrol was followed by HPLC analysis of 5-ml samples during the growth of the culture (Fig. 3A). During logarithmic cell growth (up to 24 h), the amount of resveratrol increased to 12 to 20 mg/liter, while the p-coumaric acid concentration dropped to 0.2 mM after 20 h. During the subsequent stationary phase, both the concentration of resveratrol and that of p-coumaric acid decreased to undetectable levels.


Figure 2
View larger version (14K):
[in this window]
[in a new window]
  		FIG. 2. HPLC analysis of resveratrol produced by E. coli at 307 nm. The upper chromatogram (A) was derived from an extract of a culture of E. coli BL21 plus pAC-4CL-STS grown with p-coumaric acid for 20 h. Culture medium was separated by an HPLC setup as described in reference 2, and absorbance was recorded at 307 nm. The lower chromatogram (B) shows the same for control E. coli BL21 plus pACYC-DUET1. The peak at 17 min represents p-coumaric acid, and the peak at 28.9 min represents resveratrol. The absorption spectrum of the peak at 28.9 min is shown in the "PDA" inset, while the mass spectrum, recorded with a QTOF ULTIMA mass spectrometer (negative electrospray ionization mode) is shown in the "MS" inset.


Figure 3
View larger version (20K):
[in this window]
[in a new window]
  		FIG. 3. Production of resveratrol in E. coli (A) and S. cerevisiae (B) over time. Each graph displays the concentration of resveratrol in mg/liter in the culture medium as measured after extraction, the concentration of p-coumaric acid (p-CA) in g/liter, and the density of the culture (no absolute values indicated). The values shown are averages of two measurements of individual cultures.

As a next step towards a food-grade production system, we expressed the same genes in Saccharomyces cerevisiae. For that purpose, the 4CL2 and STS genes were assembled into a construct that can be integrated into the yeast LEU2 locus (Fig. 4). In this construct, the 4CL gene is under the control of the GAL10 promoter, while the STS gene is under control of the GAL1 promoter. Upon transformation of yeast strain CEN.PK 113-3b (ura3 his3), integration events were selected for by using 25 mg/liter chlorsulfuron methyl (Supelco) (6) and were confirmed by PCR analysis. Flask cultures of the recombinant yeast colonies were grown in 50 ml yeast nitrogen base medium (28°C, 250 rpm), supplemented with 5 mM p-coumaric acid and 2% galactose to induce gene expression. Expression was continued over several days, while 5-ml samples were taken regularly and analyzed by HPLC. In STS-positive yeast clones, resveratrol was observed to accumulate over time (Fig. 3B), starting at 24 h, when the growth of the cell culture had reached a plateau. Unlike in E. coli, the amount of resveratrol increased during the stationary culture phase, to about 5.8 mg/liter (corresponding to 25 µM) at 96 h. While in E. coli no by-product formation was observed, in the yeast medium a significant additional HPLC peak (Rf = 15.1 min, {lambda}max = 273 nm) was found to occur during the later phases of growth. This compound was identified as hydroxyphenyl-propionic acid (Fig. 1) by comparison with reference standards and mass spectrometry ([M-H]– = 165.0559 m/z). The concentration of this compound increased up to 3 mM. Its synthesis appeared to depend on the presence of the 4CL-STS expression construct, since this peak was absent in untransformed yeast cultures when incubated with p-coumaric acid.


Figure 4
View larger version (14K):
[in this window]
[in a new window]
  		FIG. 4. Cassette for integration of STS and 4CL into the yeast genome. LEU21-546, LEU2 gene from nucleotides 1 to 546 of the coding region; Pi, promoter of the ILV2 gene; ILV2-SMR, sulfometuron methyl resistance gene; Ti, terminator of the ILV2 gene; Tc, terminator of the CYC gene; STS, coding region of the grape STS gene; PGAL1, promoter of the GAL1 gene; PGAL10, promoter of the GAL10 gene; 4CL, coding region of the 4CL2 gene from tobacco; Ta, terminator of the ADH1 gene; LEU2547-1060, LEU2 gene from nucleotides 547 to 1060 of the coding region; PacI, unique PacI restriction site.

Data from a recent paper (1) indicated that, in yeast, resveratrol was produced predominantly in the form of piceid (trans-resveratrol-3-O-ß-glucoside), although in minute quantities. However, at the retention time of piceid no compound was observed in the medium or cells of our transgenic yeast strains. Incubation of culture medium or yeast cell lysate with almond ß-glucosidase (Sigma) did not result in an increase in the amount of detectable resveratrol aglycone. Moreover, in our system, the levels of unglucosylated resveratrol were more than 3 orders of magnitude higher (5.8 mg/liter) than the level of piceid previously reported for yeast (1.5 µg/liter [1]).

In the past few years, a number of results have been published on the production in microorganisms of plant-specific polyphenols, mainly naringenin, to different levels (0.45 mg/liter [3], 7 mg/liter [4], and 20 mg/liter [10]). During review of the manuscript, a report on the production of resveratrol in E. coli by use of a peanut STS gene appeared (11). Our data indicate that the recombinant yeast expression platform, using the same biosynthetic genes, is not much less efficient than E. coli. Thus, yeast is capable of producing high levels of resveratrol from inexpensive plant-derived precursors, contrary to previously published data (1). The advantage of yeast over E. coli is its food-grade status, which should, in principle, allow for applications in human nutrition. Interestingly, in both systems the desired product accumulated naturally in the medium rather than in the cells. This is particularly advantageous considering the envisaged commercial production system and its commercial viability. We conclude that economic resveratrol production is viable in a food-grade yeast.


arrow
ACKNOWLEDGMENTS
 
This research was carried out as part of the EU Sixth Framework project FOOD-CT-2005-007130 "FLORA."

The CEN.PK yeast strain was courtesy of Paul van Heusden, and the ILV2-SMR gene was courtesy of Brigitte Rønnow.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Plant Research International, P.O. Box 16, 6700 AA Wageningen, The Netherlands. Phone: 31-317-477001. Fax: 31-317-418094. E-mail: Jules.Beekwilder{at}wur.nl. Back


arrow
REFERENCES
 
    1
  1. Becker, J. V. W., G. O. Armstrong, M. J. Van der Merwe, M. G. Lambrechts, M. A. Vivier, and I. S. Pretorius. 2003. Metabolic engineering of Saccharomyces cerevisiae for the synthesis of the wine-related antioxidant resveratrol. FEMS Yeast Res. 4:79-85.[CrossRef][Medline]
    2. 2
  2. Beekwilder, J., H. Jonker, P. Meesters, R. D. Hall, I. M. van der Meer, and C. H. R. de Vos. 2005. Antioxidants in raspberry: on-line analysis links antioxidant activity to a diversity of individual metabolites. J. Agric. Food Chem. 53:3313-3320.[CrossRef][Medline]
    3. 3
  3. Hwang, E. I., M. Kaneko, Y. Ohnishi, and S. Horinouchi. 2003. Production of plant-specific flavanones by Escherichia coli containing an artificial gene cluster. Appl. Environ. Microbiol. 69:2699-2706.[Abstract/Free Full Text]
    4. 4
  4. Jiang, H. X., K. V. Wood, and J. A. Morgan. 2005. Metabolic engineering of the phenylpropanoid pathway in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 71:2962-2969.[Abstract/Free Full Text]
    5. 5
  5. Lee, D., and C. J. Douglas. 1996. Two divergent members of a tobacco 4-coumarate:coenzyme A ligase (4CL) gene family—cDNA structure, gene inheritance and expression, and properties of recombinant proteins. Plant Physiol. 112:193-205.[Abstract]
    6. 6
  6. Ronnow, B., L. Olsson, J. Nielsen, and J. D. Mikkelsen. 1999. Derepression of galactose metabolism in melibiase producing bakers' and distillers' yeast. J. Biotechnol. 72:213-228.[CrossRef][Medline]
    7. 7
  7. Schijlen, E., C. H. R. de Vos, H. Jonker, H. van den Broeck, J. Molthoff, A. van Tunen, S. Martens, and A. Bovy. 2006. Pathway engineering for healthy phytochemicals leading to the production of novel flavonoids in tomato fruit. Plant Biotechnol. J., 4:433-444.
    8. 8
  8. Signorelli, P., and R. Ghidoni. 2005. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 16:449-466.[CrossRef][Medline]
    9. 9
  9. Sparvoli, F., C. Martin, A. Scienza, G. Gavazzi, and C. Tonelli. 1994. Cloning and molecular analysis of structural genes involved in flavonoid and stilbene biosynthesis in grape (Vitis vinifera L.). Plant Mol. Biol. 24:743-755.[CrossRef][Medline]
    10. 10
  10. Watts, K. T., P. C. Lee, and C. Schmidt-Dannert. 2004. Exploring recombinant flavonoid biosynthesis in metabolically engineered Escherichia coli. Chembiochem 5:500-507.[CrossRef][Medline]
    11. 11
  11. Watts, K. T., P. C. Lee, and C. Schmidt-Dannert. 2006. Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli. BMC Biotechnol. 6:22.[CrossRef][Medline]

Applied and Environmental Microbiology, August 2006, p. 5670-5672, Vol. 72, No. 8
0099-2240/06/$08.00+0     doi:10.1128/AEM.00609-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Katsuyama, Y., Matsuzawa, M., Funa, N., Horinouchi, S. (2008). Production of curcuminoids by Escherichia coli carrying an artificial biosynthesis pathway. Microbiology 154: 2620-2628 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beekwilder, J.
Right arrow Articles by Bovy, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beekwilder, J.
Right arrow Articles by Bovy, A.
Agricola
Right arrow Articles by Beekwilder, J.
Right arrow Articles by Bovy, A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»